Literature DB >> 19349926

Structural brain correlates of verbal fluency in Parkinson's disease.

Joana B Pereira1, Carme Junqué, Maria J Martí, Blanca Ramirez-Ruiz, David Bartrés-Faz, Eduard Tolosa.   

Abstract

Verbal fluency tests are often used to assess cognitive dysfunction in Parkinson's disease. These tests have been found to be impaired even in initial stages of this illness. We applied voxel-based morphometry to investigate the neuroanatomic substrates of semantic and phonemic fluency impairment. Correlations between gray matter density and semantic as well as phonemic fluency performance were performed in 32 nondemented Parkinson's disease patients. We found that gray matter of temporal, frontal and cerebellar areas correlated with semantic fluency scores. In contrast, no gray matter correlations were found for phonemic fluency or for general cognitive functions. These results suggest that semantic fluency impairment is reflecting structural gray matter changes in regions involved in language networks.

Entities:  

Mesh:

Year:  2009        PMID: 19349926     DOI: 10.1097/WNR.0b013e328329370b

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  26 in total

1.  Sentence processing in Lewy body spectrum disorder: the role of working memory.

Authors:  Rachel G Gross; Corey T McMillan; Keerthi Chandrasekaran; Michael Dreyfuss; Sharon Ash; Brian Avants; Philip Cook; Peachie Moore; David J Libon; Andrew Siderowf; Murray Grossman
Journal:  Brain Cogn       Date:  2012-01-02       Impact factor: 2.310

2.  Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorder.

Authors:  Murray Grossman; Rachel G Gross; Peachie Moore; Michael Dreyfuss; Corey T McMillan; Philip A Cook; Sherry Ash; Andrew Siderowf
Journal:  Brain Lang       Date:  2011-09-29       Impact factor: 2.381

3.  The organization and anatomy of narrative comprehension and expression in Lewy body spectrum disorders.

Authors:  Sharon Ash; Sharon X Xie; Rachel Goldmann Gross; Michael Dreyfuss; Ashley Boller; Emily Camp; Brianna Morgan; Jessica O'Shea; Murray Grossman
Journal:  Neuropsychology       Date:  2012-02-06       Impact factor: 3.295

4.  Neurocognitive and atrophic patterns in Parkinson's disease based on subjective memory complaints.

Authors:  Jin Yong Hong; Ji Eun Lee; Young H Sohn; Phil Hyu Lee
Journal:  J Neurol       Date:  2012-08       Impact factor: 4.849

5.  The organization of narrative discourse in Lewy body spectrum disorder.

Authors:  Sharon Ash; Corey McMillan; Rachel G Gross; Philip Cook; Brianna Morgan; Ashley Boller; Michael Dreyfuss; Andrew Siderowf; Murray Grossman
Journal:  Brain Lang       Date:  2011-10       Impact factor: 2.381

6.  Whole-brain proton MR spectroscopic imaging in Parkinson's disease.

Authors:  Bonnie E Levin; Heather L Katzen; Andrew Maudsley; Judith Post; Connie Myerson; Varan Govind; Fatta Nahab; Blake Scanlon; Aaron Mittel
Journal:  J Neuroimaging       Date:  2012-12-10       Impact factor: 2.486

7.  Initial cognitive decline is associated with cortical thinning in early Parkinson disease.

Authors:  Joana B Pereira; Per Svenningsson; Daniel Weintraub; Kolbjørn Brønnick; Alexander Lebedev; Eric Westman; Dag Aarsland
Journal:  Neurology       Date:  2014-05-07       Impact factor: 9.910

8.  Differentiating Patients with Parkinson's Disease from Normal Controls Using Gray Matter in the Cerebellum.

Authors:  Ling-Li Zeng; Liang Xie; Hui Shen; Zhiguo Luo; Peng Fang; Yanan Hou; Beisha Tang; Tao Wu; Dewen Hu
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

9.  Semantic profiles in mild cognitive impairment associated with Alzheimer's and Parkinson's diseases.

Authors:  Marco Guidi; Lucia Paciaroni; Susy Paolini; Osvaldo Scarpino; David J Burn
Journal:  Funct Neurol       Date:  2015 Apr-Jun

10.  Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease.

Authors:  J Vincent Filoteo; Jason D Reed; Irene Litvan; Deborah L Harrington
Journal:  Mov Disord       Date:  2013-09-03       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.